4,6-diaryl pyrimidones as constrained chalcone analogues: Design, synthesis and evaluation as antiproliferative agents

Dinesh Kumar, Kunal Nepali, P. M.S. Bedi, Suresh Kumar, Fayaz Malik, Subheet Jain

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

4,6-diarylpyrimidones as constrained chalcone analogues have been synthesised in the present study. The synthesised compounds were evaluated against a panel of human cancer cell lines. Striking selectivity was displayed by the compounds against MiaPaCa (Pancreatic) cell lines while PC-3 (prostate) and A-549 (lung) cell lines were almost resistant to the exposure of the test compounds. Compound SK – 25 exhibited remarkable cytotoxicity against MiaPaca-2 cell line with an IC50 value of 1.95 μM and was found to induce apoptosis evidenced through phase contrast microscopy, DAPI staining and mitochondrial membrane potential loss. The cell phase distribution studies indicated that the apoptotic population increased from 1.79% in control sample to 30.33 % in sample treated with 20 μM compound SK-25.

Original languageEnglish
Pages (from-to)793-803
Number of pages11
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume15
Issue number6
DOIs
Publication statusPublished - Jul 1 2015
Externally publishedYes

Keywords

  • Apoptosis
  • Cell cycle
  • Chalcone
  • Contrained
  • Cytotoxic
  • Pyrimidones

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Cancer Research

Fingerprint Dive into the research topics of '4,6-diaryl pyrimidones as constrained chalcone analogues: Design, synthesis and evaluation as antiproliferative agents'. Together they form a unique fingerprint.

Cite this